News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

New Optune You-Tube Video Channel

Al's Comment:

 There is a new video on that page which shows the effect Optune has on dividing cancer cells. They show cancer cells in culture dividing, the ones on the left are treated with Optune, the ones on the left are not treated.  Aside from the amazing video of showing cells blow up when they try to divide, the end result is a huge reduction in the number of tumor cells at the end.


Posted on: 04/25/2015

New Optune YoutTube Video Channel 

www.youtube.com/user/Optuneus

It is with great excitement that we officially announce the launch of our Optune™ YouTube channel. This channel is dedicated to the education and support of future and current Optune patients with recurrent glioblastoma (GBM) and their care teams in the United States.

Please visit us at http://www.youtube.com/OptuneUS and subscribe to the channel. We plan to update this YouTube channel periodically with new
videos and strive to provide valuable content
for healthcare provider, patient, and caregiver audiences. 

Indications for Use 

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically confirmed glioblastoma multiforme (GBM), following histologically-or radiologically-confirmed recurrence in the supra-tentorial region of the brain after receiving chemotherapy. The device is intended to be used as a monotherapy, and is intended as an alternative to standard medical therapy for GBM after surgical and radiation options have been exhausted. 

Summary of Important Safety Information 

The most common device related adverse events observed with Optune were mild to moderate skin irritations seen in 16% of the patients. In rare cases headaches, falls, fatigue, muscle twitching, or skin ulcers were also observed.

 

For full prescribing information refer to the Instructions for Use (IFU) at www.Optune.com/safety.

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740